Table III.

Multivariate analysis of LMO2 expression for clinical outcome of adult patients with B-cell acute lymphoblastic leukemia.

	Overall survival time			Disease-free survival
Variable	HR	95% CI for relative risk	P-value	HR	95% CI for relative risk	P-value
LMO2 expression	0.60	0.32–0.85	0.010	0.56	0.24–0.90	0.020
Age	0.80	0.55–0.95	0.425	0.85	0.49–0.98	0.456
Gender	0.78	0.32–1.05	0.892	0.94	0.60–1.05	0.680
Immunophenotype	1.00	0.87–1.24	0.576	1.02	0.76–1.24	0.605
WBC >50×109 cells/l	0.93	0.69–1.06	0.357	0.82	0.62–1.18	0.822

LMO2, LIM domain only protein 2; HR, hazards ratio; CI, confidence interval; WBC, white blood cells.